GlassScriptPhysician profile
Vipul D Sharma
NPI 1538504949
$4,537.00
in general payments reported to CMS, 2019-2025
19 companies · $2,937 in 2025
The $2,937 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.16 · 2020: $157 · 2021: $230 · 2023: $59.33 · 2024: $1,128 · 2025: $2,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,124.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,064.76 | 2024-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $643.75 | 2024-2025 | Evoke |
| Curonix LLC | $438.84 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $371.99 | 2023-2025 | |
| Boston Scientific Corporation | $306.62 | 2021-2025 | General - Pain Management, Artisan |
| Medtronic, INC. | $227.07 | 2021-2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $218.40 | 2024-2025 | Sprint Pns System |
| Stryker Corporation | $198.32 | 2021-2025 | Mild Device Kit |
| Globus Medical, INC. | $178.10 | 2025 | Senza |
| Vertos Medical, INC. | $162.77 | 2021-2024 | Mild Device Kit |
| Medtronic USA, INC. | $156.99 | 2020 | |
| Nevro Corp. | $154.19 | 2024 | Senza |
| Eisai INC. | $122.85 | 2024 | |
| Foundation Fusion Solutions, LLC | $98.81 | 2025 | |
| Angiodynamics, INC. | $66.41 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $54.35 | 2025 | |
| Electronic Waveform Lab, INC. | $25.33 | 2025 | |
| Djo, LLC | $25.16 | 2019 | |
| Xeris Pharmaceuticals, INC. | $22.29 | 2023 | Keveyis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipul Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.